{
    "id": 26872,
    "fullName": "PIK3CA K944N",
    "impact": "missense",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "PIK3CA K944N lies within the PI3K/PI4K domain of the Pik3ca protein (UniProt.org). K944N results in activation of Pik3ca signaling as indicated by increased phosphorylation of Akt and Mapk3/Mapk1 (Erk1/2), and confers resistance to Erbitux (cetuximab) in culture (PMID: 28424201) and therefore, is predicted to result in a gain of Pik3ca protein function.",
            "references": [
                {
                    "id": 9728,
                    "pubMedId": 28424201,
                    "title": "PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28424201"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5290,
        "geneSymbol": "PIK3CA",
        "terms": [
            "PIK3CA",
            "CLAPO",
            "CLOVE",
            "CWS5",
            "MCAP",
            "MCM",
            "MCMTC",
            "p110-alpha",
            "PI3K",
            "PI3K-alpha"
        ]
    },
    "variant": "K944N",
    "createDate": "08/16/2017",
    "updateDate": "09/14/2018",
    "referenceTranscriptCoordinates": {
        "id": 171939,
        "transcript": "NM_006218",
        "gDna": "chr3:g.179230272A>C",
        "cDna": "c.2832A>C",
        "protein": "p.K944N",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11717,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, PIK3CA K944N was identified as a potential mechanism for acquired Erbitux (cetuximab) resistance in two colorectal cancer patients, which is supported by cell culture studies demonstrating resistance to Erbitux (cetuximab) and Fluorouracil combination treatment in colorectal cancer cells over expressing PIK3CA K944N (PMID: 28424201).",
            "molecularProfile": {
                "id": 28196,
                "profileName": "PIK3CA K944N"
            },
            "therapy": {
                "id": 2000,
                "therapyName": "Cetuximab + Fluorouracil",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 9728,
                    "pubMedId": 28424201,
                    "title": "PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28424201"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28196,
            "profileName": "PIK3CA K944N",
            "profileTreatmentApproaches": [
                {
                    "id": 17503,
                    "name": "Akt2 Inhibitor",
                    "profileName": "PIK3CA K944N"
                },
                {
                    "id": 17507,
                    "name": "mTORC1 Inhibitor",
                    "profileName": "PIK3CA K944N"
                },
                {
                    "id": 17504,
                    "name": "PIK3CA inhibitor",
                    "profileName": "PIK3CA K944N"
                },
                {
                    "id": 17508,
                    "name": "mTOR Inhibitor",
                    "profileName": "PIK3CA K944N"
                },
                {
                    "id": 17510,
                    "name": "mTORC2 Inhibitor",
                    "profileName": "PIK3CA K944N"
                },
                {
                    "id": 17509,
                    "name": "PI3K Inhibitor (Pan)",
                    "profileName": "PIK3CA K944N"
                },
                {
                    "id": 17506,
                    "name": "Akt Inhibitor (Pan)",
                    "profileName": "PIK3CA K944N"
                },
                {
                    "id": 17505,
                    "name": "Akt1 Inhibitor",
                    "profileName": "PIK3CA K944N"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 171940,
            "transcript": "XM_011512894",
            "gDna": "chr3:g.179230272A>C",
            "cDna": "c.2832A>C",
            "protein": "p.K944N",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 171939,
            "transcript": "NM_006218",
            "gDna": "chr3:g.179230272A>C",
            "cDna": "c.2832A>C",
            "protein": "p.K944N",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 171938,
            "transcript": "XM_006713658",
            "gDna": "chr3:g.179230272A>C",
            "cDna": "c.2832A>C",
            "protein": "p.K944N",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}